tirzepatide for the treatment of obstructive sleep apnea and obesity VisualAbstract: Improved Outcomes in Patients with Sleep Apnea and Weight Loss:

[Accessed 20 January 2026] Behavioural interventions in obesity

We aim to investigate the utility of genetic risk score (GRS) in the diabetes classification in Chinese individuals

Barbatelli G, et al

The resulting downstream effects include decreased osteoclast-mediated bone resorption, improved low-density lipoprotein clearance, and modulation of hypothalamic thermoregulatory centers, translating to clinical relief of vasomotor instability

First, leaving aside the obvious yet relatively uncommon problem of overeating as a cause of weight gain, the reason that most people gain weight in the first place is because they have abnormally low metabolisms

Further, in a phase 2 human clinical study with tirzepatide in conjunction with regulated nutrition and lifestyle with or without metformin, a dose-dependent impact on HbA1c and weight loss was observed, which was larger than that of the selective GLP-1 RA dulaglutide